X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GSK Pharma: Dismal show continues - Views on News from Equitymaster
StockSelect
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma: Dismal show continues
Aug 1, 2007

Performance summary
  • Revenues decline by 3% YoY on the back of absence of revenues from the animal health business, which was divested in 3QCY06.

  • EBDITA margins remain stable at 30.9% led by an increased emphasis on improving the product mix by focusing on priority brands.

  • PAT grows by a staid 6% YoY despite the 2% YoY fall in operating profits due to a higher other income and lower depreciation charges.

Financial performance: A snapshot
(Rs m) 2QCY06 2QCY07 Change 1HCY06 1HCY07 Change
Net sales 4,073 3,956 -2.9% 8,335 8,171 -2.0%
Expenditure 2,822 2,733 -3.1% 5,673 5,497 -3.1%
Operating profit (EBDITA) 1,252 1,223 -2.3% 2,663 2,674 0.4%
EBDITA margin (%) 30.7% 30.9%   31.9% 32.7%  
Other income 183 312 70.5% 405 584 44.2%
Depreciation 39 37 -4.4% 77 74 -3.5%
Profit before tax 1,396 1,498 7.3% 2,991 3,184 6.5%
Tax 485 534 10.0% 1,046 1,107 5.8%
Extraordinary item - -   (22) -  
Profit after tax/(loss) 911 964 5.9% 1,923 2,077 8.0%
Net profit margin (%) 22.4% 24.4%   23.1% 25.4%  
No. of shares (m) 84.7 84.7   84.7 84.7  
Diluted earnings per share (Rs)*         44.2  
Price to earnings ratio (x)         25.5  

To Read the Full Story, Subscribe or Sign In


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Feb 20, 2018 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS